Evidence map›Paper›PMID 32001550›Full record

ArticleeNeuro

Collapsin Response Mediator Protein 4 (CRMP4) Facilitates Wallerian Degeneration and Axon Regeneration following Sciatic Nerve Injury.

Marie-Pier Girouard, Tristan Simas, Luyang Hua, Barbara Morquette, Mohamad R Khazaei, Nicolas Unsain, Aaron D Johnstone, Isabel Rambaldi, Ricardo L Sanz, Marie-Eve Di Raddo and 7 more

Open access · goldAbstract read
In one paragraph

Article in eNeuro. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. The peripheral Atf3Acta biochimica et biophysica Sinica · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 3 countries.

Marie-Pier GirouardDepartment of Neurology and Neurosurgery, Montréal Neurological Institute and Hospital, Montréal, Québec H3A 2B4, Canada.
Tristan SimasDepartment of Neurology and Neurosurgery, Montréal Neurological Institute and Hospital, Montréal, Québec H3A 2B4, Canada.
Luyang HuaDepartment of Neurology and Neurosurgery, Montréal Neurological Institute and Hospital, Montréal, Québec H3A 2B4, Canada.ORCID 0000-0001-8266-7914
Barbara MorquetteDepartment of Neurology and Neurosurgery, Montréal Neurological Institute and Hospital, Montréal, Québec H3A 2B4, Canada.
Mohamad R KhazaeiDepartment of Neurology and Neurosurgery, Montréal Neurological Institute and Hospital, Montréal, Québec H3A 2B4, Canada.
Nicolas UnsainInstituto de Investigación Médica Mercedes y Martín Ferreyra (INIMEC), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), 5016 Córdoba, Argentina.
Aaron D JohnstoneDepartment of Neurology and Neurosurgery, Montréal Neurological Institute and Hospital, Montréal, Québec H3A 2B4, Canada.
Isabel RambaldiDepartment of Neurology and Neurosurgery, Montréal Neurological Institute and Hospital, Montréal, Québec H3A 2B4, Canada.
Ricardo L SanzDepartment of Neurology and Neurosurgery, Montréal Neurological Institute and Hospital, Montréal, Québec H3A 2B4, Canada.
Marie-Eve Di RaddoMcGill University, Montréal, Québec H3A 0G4, Canada.
Kanchana K GamageDepartment of Biology, University of Virginia, Charlottesville, Virginia 22903.ORCID 0000-0001-7687-1732
Yu YongDepartment of Biology, University of Virginia, Charlottesville, Virginia 22903.
Dianna E WillisBrain and Mind Research Institute, Weill Cornell Medicine, New York, New York 10065.ORCID 0000-0003-1442-3533
Valerie M K VergeDepartment of Anatomy, Physiology and Pharmacology, University of Saskatchewan-CMSNRC, Saskatoon, Saskatchewan S7N 5E5, Canada.
Philip A BarkerDepartment of Neurology and Neurosurgery, Montréal Neurological Institute and Hospital, Montréal, Québec H3A 2B4, Canada.
Christopher DeppmannDepartment of Biology, University of Virginia, Charlottesville, Virginia 22903.
Alyson E FournierDepartment of Neurology and Neurosurgery, Montréal Neurological Institute and Hospital, Montréal, Québec H3A 2B4, Canada alyson.fournier@mcgill.ca.ORCID 0000-0002-1859-7015
Montreal Neurological Institute and Hospital · CAUniversity of Virginia · USCentro Científico Tecnológico - Tucumán · ARCornell University · USMcGill University · CAUniversity of Saskatchewan · CA

Funding

CIHR PJT 153331
6 · The paper itself

Abstract

In contrast to neurons in the CNS, damaged neurons from the peripheral nervous system (PNS) regenerate, but this process can be slow and imperfect. Successful regeneration is orchestrated by cytoskeletal reorganization at the tip of the proximal axon segment and cytoskeletal disassembly of the distal segment. Collapsin response mediator protein 4 (CRMP4) is a cytosolic phospho-protein that regulates the actin and microtubule cytoskeleton. During development, CRMP4 promotes growth cone formation and dendrite development. Paradoxically, in the adult CNS, CRMP4 impedes axon regeneration. Here, we investigated the involvement of CRMP4 in peripheral nerve injury in male and female

Indexed as

Peripheral Nerve InjuriesWallerian DegenerationAnimalsAxonsFemaleGanglia, SpinalMaleMiceMuscle ProteinsNerve RegenerationSciatic NerveSemaphorin-3AMuscle ProteinsSemaphorin-3Acalpaincollapsin response mediator proteinneuronal regenerationsciatic nerve injurysensory neuronsWallerian degeneration

Identifiers

PMID32001550
PMCPMC7053045
OpenAlexW3003595909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.